UCT Announces Launch of Public Offering of Common Stock
News provided by
Share this article
Share this article
HAYWARD, Calif., April 5, 2021 /PRNewswire/ Ultra Clean Holdings, Inc. (Nasdaq: UCTT), a leading developer and supplier of critical subsystems, ultra-high purity cleaning and analytical services primarily for the semiconductor industry, today announced that it has commenced an underwritten public offering of $175.0 million of its common stock. All of the shares of common stock to be sold in the offering will be offered by the Company. In addition, the Company expects to grant the underwriters a 30-day option to purchase additional shares of Ultra Clean s common stock at the public offering price, less the underwriting discount. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Windtree Therapeutics Announces Closing of $30 0 Million Public Offering
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Windtree Therapeutics Announces Closing of $30 0 Million Public Offering
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Message :
Required fields
BERKELEY HEIGHTS, N.J., March 12, 2021 (GLOBE NEWSWIRE) Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; Cyclacel or the Company ), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the pricing of an underwritten public offering of 1,807,143 shares of its common stock, offered at a price of $7.00 to the public. Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 271,071 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares in the offering are being offered by the Company. The offering is expected to close on or about March 16, 2021, subject to customary closing conditions. The gross proceeds to the Company from this offering are expected to be approximately $12.65 million, before deducting underwriting discounts and commissions and other estimated offering expenses payab
Cyclacel Pharmaceuticals Prices $12 65 Million Underwritten Public Offering of Common Stock
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.